Log in

CVE:VIVAvivagen News Headlines

C$0.45
-0.02 (-4.26 %)
(As of 07/13/2020 02:12 AM ET)
Add
Compare
Today's Range
C$0.44
Now: C$0.45
C$0.47
50-Day Range
C$0.46
MA: C$0.53
C$0.65
52-Week Range
C$0.40
Now: C$0.45
C$0.77
Volume61,000 shs
Average Volume70,971 shs
Market CapitalizationC$18.74 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Avivagen (CVE VIV) News Headlines

Source:
DateHeadline
Avivagen non-antibiotic feed additive OKd in BrazilAvivagen non-antibiotic feed additive OK'd in Brazil
seekingalpha.com - June 24 at 8:12 AM
Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2020Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2020
www.businesswire.com - June 2 at 6:19 PM
Global Metabolic Partnering 2014-2020: Deal Trends, Players and Financials - ResearchAndMarkets.comGlobal Metabolic Partnering 2014-2020: Deal Trends, Players and Financials - ResearchAndMarkets.com
www.businesswire.com - May 20 at 10:50 PM
Avivagen Announces Increase in North American OxC-beta™ Livestock Order Following Successful Dairy Field TestsAvivagen Announces Increase in North American OxC-beta™ Livestock Order Following Successful Dairy Field Tests
www.benzinga.com - May 20 at 7:39 AM
Avivagen Announces Results From Its Annual General Meeting April 8, 2020Avivagen Announces Results From Its Annual General Meeting April 8, 2020
www.businesswire.com - April 8 at 7:19 PM
Avivagen Secures New Sales of OxC-beta™ in Taiwan and ThailandAvivagen Secures New Sales of OxC-beta™ in Taiwan and Thailand
www.businesswire.com - April 2 at 11:14 AM
Avivagen Announces First Purchase Orders of OxC-beta™ Livestock in MexicoAvivagen Announces First Purchase Orders of OxC-beta™ Livestock in Mexico
www.businesswire.com - March 25 at 9:13 AM
Avivagen Inc. to Issue Shares in lieu of Annual Maintenance FeeAvivagen Inc. to Issue Shares in lieu of Annual Maintenance Fee
www.businesswire.com - March 23 at 7:18 PM
Avivagen to launch OxC-Beta for COVID-19Avivagen to launch OxC-Beta for COVID-19
seekingalpha.com - March 17 at 12:40 PM
BRIEF-Avivagen Accelerates Plans For Commercial Launch Of Its Oxc-Beta Technology For Human Use In Response To Covid-19BRIEF-Avivagen Accelerates Plans For Commercial Launch Of Its Oxc-Beta Technology For Human Use In Response To Covid-19
www.reuters.com - March 17 at 7:39 AM
BRIEF-Avivagen Announces Positive Results From New Zealand Oxc-Beta Livestock Dairy Trial For Use Against Sub-Clinical MastitisBRIEF-Avivagen Announces Positive Results From New Zealand Oxc-Beta Livestock Dairy Trial For Use Against Sub-Clinical Mastitis
www.reuters.com - February 24 at 6:00 PM
BRIEF-Avivagen Finalizes Distribution Agreement With Inphilco In PhilippinesBRIEF-Avivagen Finalizes Distribution Agreement With Inphilco In Philippines
www.msn.com - February 18 at 9:23 AM
Avivagen Finalizes Distribution Agreement with INPHILCO in the PhilippinesAvivagen Finalizes Distribution Agreement with INPHILCO in the Philippines
www.businesswire.com - February 18 at 9:23 AM
Avivagen Announces CEO Update to ShareholdersAvivagen Announces CEO Update to Shareholders
www.businesswire.com - January 29 at 7:50 AM
Avivagen Announces Closing of Additional $1.75 Million Private PlacementAvivagen Announces Closing of Additional $1.75 Million Private Placement
www.businesswire.com - January 27 at 6:17 PM
Avivagen Announces Update on Private Placement ProcessAvivagen Announces Update on Private Placement Process
finance.yahoo.com - January 20 at 10:10 PM
VIVXF: Preparing to Move OxC-beta™ into China…VIVXF: Preparing to Move OxC-beta™ into China…
finance.yahoo.com - January 10 at 12:47 PM
Avivagen closes $1.25M private placementAvivagen closes $1.25M private placement
seekingalpha.com - January 3 at 4:41 PM
Avivagen Announces Closing of $1.25 Million Private PlacementAvivagen Announces Closing of $1.25 Million Private Placement
www.businesswire.com - January 3 at 4:41 PM
BRIEF-Avivagen Entered Into An Agreement With Research Subsidiary Of Cofco Biotechnology Co. Ltd.BRIEF-Avivagen Entered Into An Agreement With Research Subsidiary Of Cofco Biotechnology Co. Ltd.
www.msn.com - December 17 at 10:58 PM
Avivagen teams up with COFCO Biotech for OxC-beta Livestock approval in ChinaAvivagen teams up with COFCO Biotech for OxC-beta Livestock approval in China
seekingalpha.com - December 17 at 7:48 AM
BRIEF-Avivagen Signs Memorandum Of Understanding With Distribution Agent In Asia-PacificBRIEF-Avivagen Signs Memorandum Of Understanding With Distribution Agent In Asia-Pacific
www.msn.com - December 16 at 10:33 PM
Avivagen Signs Memorandum of Understanding with Distribution Agent in Asia-PacificAvivagen Signs Memorandum of Understanding with Distribution Agent in Asia-Pacific
www.businesswire.com - December 16 at 7:31 AM
Avivagen Receives Approval for Use of OxC-beta™ Livestock in MalaysiaAvivagen Receives Approval for Use of OxC-beta™ Livestock in Malaysia
finance.yahoo.com - December 5 at 7:39 PM
CHEXF: Initiating Coverage of Avivagen, Inc.; Combating Antibiotic Resistance at the Source…CHEXF: Initiating Coverage of Avivagen, Inc.; Combating Antibiotic Resistance at the Source…
finance.yahoo.com - November 19 at 11:19 PM
Avivagen Inc.Avivagen Inc.
www.barrons.com - November 8 at 11:26 PM
Avivagen IncAvivagen Inc
www.bloomberg.com - October 30 at 11:19 PM
Avivagen to Pursue Regulatory Approval in MexicoAvivagen to Pursue Regulatory Approval in Mexico
www.bloomberg.com - October 9 at 10:01 PM
Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2019Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2019
www.businesswire.com - September 6 at 5:41 PM
Demand for OxC-beta™ Livestock Continues to Grow as Avivagen Secures Another Order in Asia-PacificDemand for OxC-beta™ Livestock Continues to Grow as Avivagen Secures Another Order in Asia-Pacific
finance.yahoo.com - August 26 at 3:18 PM
Avivagens OxC-beta Livestock now approved in Mexico.Avivagen's OxC-beta Livestock now approved in Mexico.
seekingalpha.com - August 20 at 10:58 AM
This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.